Look Up > Drugs > Carbachol
Carbachol
Pronunciation
U.S. Brand Names
Generic Available
Synonyms
Pharmacological Index
Use
Pregnancy Risk Factor
Contraindications
Warnings/Precautions
Adverse Reactions
Overdosage/Toxicology
Drug Interactions
Stability
Mechanism of Action
Pharmacodynamics/Kinetics
Usual Dosage
Mental Health: Effects on Mental Status
Mental Health: Effects on Psychiatric Treatment
Dental Health: Local Anesthetic/Vasoconstrictor Precautions
Dental Health: Effects on Dental Treatment
Patient Information
Nursing Implications
Dosage Forms

Pronunciation
(KAR ba kole)

U.S. Brand Names
Carbastat® Ophthalmic; Carboptic® Ophthalmic; Isopto® Carbachol Ophthalmic; Miostat® Intraocular

Generic Available

No


Synonyms
Carbacholine; Carbamylcholine Chloride

Pharmacological Index

Cholinergic Agonist; Ophthalmic Agent, Antiglaucoma; Ophthalmic Agent, Miotic


Use

Lowers intraocular pressure in the treatment of glaucoma; cause miosis during surgery


Pregnancy Risk Factor

C


Contraindications

Acute iritis, acute inflammatory disease of the anterior chamber, hypersensitivity to carbachol or any component


Warnings/Precautions

Use with caution in patients undergoing general anesthesia and in presence of corneal abrasion


Adverse Reactions

1% to 10%: Ocular: Blurred vision, eye pain

<1%: Transient fall in blood pressure, headache, stomach cramps, diarrhea, ciliary spasm with temporary decrease of visual acuity, corneal clouding, persistent bullous keratopathy, postoperative keratitis, retinal detachment, transient ciliary and conjunctival injection, asthma, increased peristalsis


Overdosage/Toxicology

Symptoms of overdose include miosis, flushing, vomiting, bradycardia, bronchospasm, involuntary urination

Atropine is the treatment of choice for intoxications manifesting with significant muscarinic symptoms. Atropine I.V. 2-4 mg every 3-60 minutes (or 0.04-0.08 mg I.V. every 5-60 minutes if needed for children) should be repeated to control symptoms and then continued as needed for 1-2 days following the acute ingestion. Epinephrine 0.1-1 mg S.C. may be useful in reversing severe cardiovascular or pulmonary sequelae.


Drug Interactions

Decreased effect of carbachol possible with topical NSAIDs


Stability

Intraocular: Store at room temperature of 15°C to 30°C/59°F to 86°F

Topical: Store at 8°C to 27°C/46°F to 80°F


Mechanism of Action

Synthetic direct-acting cholinergic agent that causes miosis by stimulating muscarinic receptors in the eye


Pharmacodynamics/Kinetics

Ophthalmic instillation:

Onset of miosis: 10-20 minutes

Duration of reduction in intraocular pressure: 4-8 hours

Intraocular administration:

Onset of miosis: Within 2-5 minutes

Duration: 24 hours


Usual Dosage

Adults:

Intraocular: 0.5 mL instilled into anterior chamber before or after securing sutures


Mental Health: Effects on Mental Status

None reported


Mental Health: Effects on Psychiatric Treatment

None reported


Dental Health: Local Anesthetic/Vasoconstrictor Precautions

No information available to require special precautions


Dental Health: Effects on Dental Treatment

Ophthalmic use of carbachol has no effect on dental treatment


Patient Information

May sting on instillation; may cause headache, altered distance vision, and decreased night vision


Nursing Implications

Finger pressure should be applied on the lacrimal sac for 1-2 minutes following topical instillation; remove excess around the eye with a tissue. Instillation for miosis prior to eye surgery should be gentle and parallel to the iris face and tangential to the pupil border; discard unused portion.


Dosage Forms

Solution:

Topical, ophthalmic:

Carboptic®: 3% (15 mL)

Isopto® Carbachol: 0.75% (15 mL, 30 mL); 1.5% (15 mL, 30 mL); 2.25% (15 mL); 3% (15 mL, 30 mL)


Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved